These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1603214)

  • 41. [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients].
    Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
    Ann Med Interne (Paris); 2003 Feb; 154(1):7-11. PubMed ID: 12746654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of ursodeoxycholic acid in primary biliary cirrhosis.
    Pham NT; Hart LL
    Ann Pharmacother; 1993 Dec; 27(12):1472-4. PubMed ID: 8305782
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.
    Corpechot C; Carrat F; Bonnand AM; Poupon RE; Poupon R
    Hepatology; 2000 Dec; 32(6):1196-9. PubMed ID: 11093724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
    Angulo P; Jorgensen RA; Keach JC; Dickson ER; Smith C; Lindor KD
    Hepatology; 2000 Feb; 31(2):318-23. PubMed ID: 10655252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Medical treatment of primary biliary cirrhosis].
    Pirotte J
    Acta Gastroenterol Belg; 1990; 53(2):225-8. PubMed ID: 2267902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Primary biliary cirrhosis: progress in its therapy].
    Kuroki T; Shiomi S
    Nihon Naika Gakkai Zasshi; 1999 Apr; 88(4):615-9. PubMed ID: 10341646
    [No Abstract]   [Full Text] [Related]  

  • 47. Ursodeoxycholic acid treatment in a patient with primary biliary cirrhosis.
    Wouters RS; Bos LP; Engels LG
    Neth J Med; 1990 Aug; 37(1-2):21-3. PubMed ID: 2215828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The timing of liver transplantation in primary biliary cirrhosis.
    Angulo P; Dickson ER
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):657-68. PubMed ID: 10976021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
    Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
    Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary sclerosing cholangitis and primary biliary cirrhosis. How effective is medical therapy?
    Fennerty MB
    Postgrad Med; 1993 Nov; 94(6):81-8; 92. PubMed ID: 8234100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibrogenesis in cirrhosis. Potential for therapeutic intervention.
    Rojkind M
    Pharmacol Ther; 1992; 53(1):81-104. PubMed ID: 1641403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Therapy for refractory primary biliary cirrhosis].
    Han Y; Zhu JY
    Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):330-2. PubMed ID: 22988584
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical use of corticosteroid and immunosuppressive drugs in liver disease.
    Fung WP
    Drugs; 1974; 8(2):139-45. PubMed ID: 4434868
    [No Abstract]   [Full Text] [Related]  

  • 55. Emerging therapies for liver fibrosis.
    Fowell AJ; Iredale JP
    Dig Dis; 2006; 24(1-2):174-83. PubMed ID: 16699275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunosuppressive therapy for primary biliary cirrhosis.
    Beukers R; Schalm SW
    J Hepatol; 1992 Jan; 14(1):1-6. PubMed ID: 1737909
    [No Abstract]   [Full Text] [Related]  

  • 57. [Immunosuppressive agents in treatment of liver cirrhosis: personal experience].
    Laurent J; Mauuary G; Bas M; Vautrin D; Drouin P; Gaucher P; Heully F
    Acta Gastroenterol Belg; 1968 Nov; 31(11):780-5. PubMed ID: 5746039
    [No Abstract]   [Full Text] [Related]  

  • 58. Primary biliary cirrhosis: questions and promises.
    Lindor KD
    Ann Intern Med; 1997 May; 126(9):733-5. PubMed ID: 9139561
    [No Abstract]   [Full Text] [Related]  

  • 59. Biliary cirrhosis of the liver in India with special reference to its treatment.
    CARRUTHERS LB
    J Christ Med Assoc India; 1945 Sep; 20():134. PubMed ID: 21003760
    [No Abstract]   [Full Text] [Related]  

  • 60. [Deoxycholic acid in the therapy of liver cirrhosis (author's transl)].
    Fassati P; Chýle P; Fassati M; Chýle M
    Cas Lek Cesk; 1975 Oct; 114(40):1222-6. PubMed ID: 1182753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.